IV A期子宫颈原发性恶性黑色素瘤患者的根治性手术及辅助溶瘤病毒Rigvir治疗：一例报告
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir therapy: A case report.
作者信息
Pumpure Elizabete, Dručka Eva, Kigitoviča Dana, Meškauskas Raimundas, Isajevs Sergejs, Nemiro Ineta, Rasa Agnija, Olmane Evija, Zablocka Tatjana, Alberts Pēteris, Doniņa Simona
机构信息
Department of Obstetrics and Gynaecology Riga Stradiņš University Riga Latvia.
Riga Maternity Hospital Riga Latvia.
出版信息
Clin Case Rep. 2020 May 22;8(8):1538-1543. doi: 10.1002/ccr3.2928. eCollection 2020 Aug.
Abstract
Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good.
摘要
子宫颈原发性恶性黑色素瘤是一种罕见疾病，预后较差且复发率高。我们将Rigvir用作一名IVA期患者的辅助治疗。耐受性、总生存期和无进展生存期均良好。
Zotero 插件